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Long-acting muscarinic receptor antagonists (LAMAs) have been reported to attenuate cough in pre-
clinical and clinical studies. The present study was performed on rabbits to compare aclidinium and
tiotropium efficacy in the downregulation of the cough reflex. This reflex was evoked by citric acid
inhalation in unanesthetized animals and by both citric acid inhalation and mechanical stimulation of
the tracheobronchial tree in anesthetized animals 90 min following the inhalation of each drug (nebu-
lizer output always at 1 mL/min). Aclidinium 4 mg/mL and tiotropium 200 mg/mL inhaled in 1 min
proved to have similar protective effect on methacholine-induced bronchoconstriction in anesthetized
animals. The total dosage employed for aclidinium and tiotropium was 4 mg and 200 mg, respectively. In
awake animals, similar reductions in the cough number were observed following 10-min inhalation of
each drug with a slight, not significant tendency to higher antitussive effects for aclidinium. In anes-
thetized animals, 1-min inhalation of each drug caused similar depressant effects on cough responses
induced by both mechanical and chemical stimulation. A complete suppression of cough responses to
mechanical stimuli was seen in some preparations. The results strongly suggest that the LAMA-induced
downregulation of cough may be mediated not only by transient receptor potential vanilloid type 1
channels, as already reported, but also by acid-sensing ion channels and mechanoreceptors. The route of
administration along with the more rapid hydrolysis of aclidinium into inactive metabolites minimize
potential systemic side effects and give to this drug a very favorable safety profile.
© 2016 Published by Elsevier Ltd.1. Introduction
Cough is a very important airway defensive reflex [1e4] and is
the most common symptom for which patients seek medical
advice. Despite considerable efforts in the last decades to find
appropriate therapies, a safe and effective cough remedy is still
lacking [5e11].
Inhaled bronchodilator therapies with long-acting muscarinic
receptor antagonists (LAMAs) are of crucial importance for chronic
obstructive pulmonary disease (COPD) management and cause an
improvement in symptoms including cough ([12e16] also for
further Refs.). Tiotropium was the first LAMA, reaching the market; COPD, chronic obstructive
As, long-acting muscarinic
lar pressure; Pes, esophageal
istance; TRPV1, transient re-
lo).in 2002 [17]. Dicpinigaitis et al. [18] reported that tiotropium (1 h
after its inhalation) inhibits cough induced by capsaicin, a transient
receptor potential vanilloid type 1 (TRPV1) agonist, in patients with
upper respiratory tract infections. Furthermore, tiotropium inha-
lation has been shown to improve cough and other symptoms in
patients with chronic pulmonary disease due to sulphur mustard
lung injury [19]. More recently, it has been shown that inhaled
tiotropium attenuates after 1 h cough induced by capsaicin in the
guinea pig and that this effect is mediated by TRPV1 receptors
through a mechanism unrelated to its anticholinergic activity [17].
However, Clay et al. [7] have reported that, in contrast to the guinea
pig, the ozone-induced hypertussive responses to citric acid are not
inhibited by tiotropium in the rabbit.
Aclidinium bromide is a LAMA that has recently been approved
as a maintenance bronchodilator treatment for patients with COPD
and asthma [14,20,21]. In clinical studies, aclidinium provides
greater improvements in COPD symptoms, including cough, than
tiotropium and is well tolerated, with a similar safety profile
[12,13]. A recent study in the guinea pig chronically exposed to
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aclidinium, in addition to beneficial effects on lung structure and
function, shows a trend toward fewer cough episodes [22]. A
comparative study on the antitussive effects of aclidinium and
tiotropium in animal models is lacking.
The present study was undertaken to compare aclidinium and
tiotropium efficacy in the downregulation of the cough reflex in the
rabbit. The two drugs were administered by inhalation, whilst the
cough reflex was evoked by citric acid inhalation in awake animals
and by both citric acid inhalation andmechanical stimulation of the
tracheobronchial tree in anesthetized animals [8e11,23e28].
2. Materials and methods
2.1. Preliminary remarks
A total of 48 rabbits were enrolled in this study, including 2
rabbits used in preliminary trials and 6 rabbits employed to
investigate the LAMA protective action on cholinergic-induced
bronchoconstriction (see below). All animal care and experi-
mental procedures were conducted in accordance with the Italian
legislation and the official regulations of the European Community
Council on the use of laboratory animals (Directive 86/609/EEC and
2010/63/UE). The study was approved by the Animal Care and Use
Committee of the University of Florence. All efforts were made to
minimize both the number of animals used and their suffering.
Experimental procedures and details about the methods employed
have previously been described [8e11,23e28].
2.2. Effects of aclidinium or tiotropium on methacholine-induced
bronchoconstriction
The first step was to assess the concentrations of the two drugs
effective in counteracting the bronchoconstriction induced by
methacholine (MCh; Sigma-Aldrich, St. Louis, MO, USA). Experi-
ments were performed in New Zealand white rabbits (3.1e3.6 kg)
anesthetized with pentobarbital sodium (40 mg/kg i.v., supple-
mented by 2e4 mg/kg every 30 min; Sigma-Aldrich) and sponta-
neously breathing. The adequacy of anesthesia was assessed by the
absence of reflex withdrawal of the hindlimb in response to
noxious pinching of the hindpaw. The trachea was cannulated and
polyethylene catheters were inserted into a femoral artery and vein
for monitoring arterial blood pressure and for drug delivery,
respectively. The animal was placed in a prone position and fixed by
a stereotaxic head holder and vertebral clamps. Body temperature
was maintained at 38.5e39 C by a heating blanket controlled by a
rectal thermistor probe.
Esophageal pressure (Pes) was measured with a thin-walled la-
tex balloon (5-cm length) sealed over a polyethylene catheter (100-
cm length, 1.7 mm ID) with several holes in the section covered by
the balloon, positioned in the midesophagus and connected to a
pressure transducer. This corresponds to the transpulmonary
pressure (PTP) under static conditions, i.e. PTP¼ Pes  Pao, where Pao
is the alveolar pressure at end inspiration or expiration, equal to the
atmospheric pressure (see e.g. Ref. [29]). The flow signal was
recorded by means of a pneumotachograph (Fleish no. 00) and a
differential pressure transducer. The quotient of the maximum
inspiratory value of Pes and the maximum inspiratory value of tidal
flow (Fig. 1A) was considered a reliable index of lung resistance (RL;
see e.g. Refs. [30,31]). All recorded variables were acquired and
analyzed using a personal computer, equipped with an analog-to-
digital interface (Digidata 1440, Molecular Devices, Sunnyvale,
CA, USA) and appropriate software (Axoscope, Molecular Devices).
Obviously, the pneumotachograph was disconnected during drug
inhalation and connected again for RL assessment.MCh, dissolved in 0.9% NaCl solution, was delivered by an ul-
trasonic nebulizer (Projet, Artsana, Grandate, CO, Italy). The diam-
eter of the droplets ranged from 0.5 to 8 mm and the nebulizer
output was always set at 1 mL/min. The opening of the tracheal
cannula, through which the rabbits were spontaneously breathing,
was exposed to a steady stream of the nebulized MCh solution for
~30 s. In preliminary trials (two rabbits), MCh was delivered at
increasing concentrations (8, 16 and 32 mg/mL) as previously re-
ported [30] to select the dose able to induce a submaximal increase
of RL. The selected dose was 16 mg/mL. MCh challenges and
induced bronchoconstriction were evaluated before and after acli-
dinium (1, 2 and 4 mg/mL for 1 min) and tiotropium (50, 100 and
200 mg/mL for 1 min) to counteract bronchoconstriction and cause
a fall in RL > 90%. RL was measured under basal conditions and after
aerosolized MCh at 16 mg/mL. A maximum bronchoconstriction
occurred within about 1 min and was maintained during the
following 2e3 min. A rapid recovery followed. Nevertheless, a time
interval of at least 30 min was allowed before 1-min inhalation of
aclidinium or tiotropium. Ninety min after drug inhalation, the
MCh challenge was repeated and RL re-evaluated. The interval of
90 min was chosen to ensure LAMA maximum effects; both acli-
dinium and tiotropium (as other LAMAs) have been proved to fully
express their protective action on cholinergic-induced broncho-
constriction at least 1 h post-administration [32]. As illustrated in
Fig. 1, we found that the adequate concentration of each drug to
produce similar decreases in RL (range 90e95%) was 4 mg/mL of
aclidinium and 200 mg/mL of tiotropium. Since these muscarinic
receptor antagonists are long-acting [33], it was necessary to use
one animal for each drug concentration, i.e. three rabbits for each
drug.
Aclidinium bromide (ShanHai Biochempartner Co., Ltd, China)
was initially dissolved in a 0.1 N hydrochloric acid/DMSO (10:90, v/
v) mixture and then diluted in 0.9% NaCl solution at the desired
concentrations [34]. In the final solution, the concentration of
DMSOwas less than 5%. Tiotropium bromide monohydrate (Sigma-
Aldrich) was dissolved in 0.9% NaCl solution at the desired con-
centrations [7,33]. All drugs were freshly prepared on the day of
administration. Vehicle solutions administered in the same prep-
arations proved to be without effects on MCh-induced
bronchoconstriction.
We roughly estimate that over the 1-min challenge, the lungs
will be exposed to 160e200 mg of aclidinium. This was based on a
normal breathing rate of 40e50 breaths/min and a tidal volume of
~30 mL as well as a deposition rate of 10% with the aerosolized
4 mg/mL solution, which is “diluted” ~3000-fold with room air
from the nebulizer system (airflow of the nebulizer set at ~3 l/min).
Taking into consideration an aerosolized 200 mg/mL solution of
tiotropium, similar calculations led to the estimation that over the
1 min of challenge the lungs will be exposed to 8.4e10.5 mg of
tiotropium. For the total dose calculation see also Birrell et al. [17].
The same total dosage (aclidinium 4 mg and tiotropium 200 mg)
was employed to investigate drug effects on the cough reflex in
both unanesthetized and anesthetized animals. In particular, for an
evaluation of total lung exposition to aclidinium and tiotropium in
awake animals a similar calculation was performed, taking into
account in addition the 10-min duration of the inhalation period in
the Perspex chamber and accordingly reducing the concentration of
drug solutions to be aerosolized (see below).
2.3. Experiments on unanesthetized animals
Experiments were performed on 20 unanesthetized male New
Zealand white rabbits (3.0e3.6 kg). In each cough induction test
[23,24], the rabbits were placed individually into a transparent
Perspex inhalation chamber (approximately 0.050m3) and exposed
Fig. 1. Evaluation of lung resistance (RL) and protective effects exerted by aclidinium on bronchoconstriction in one rabbit. A, esophageal pressure (Pes) and flow recordings at end
inspiration (insp) were used to evaluate RL through their ratio. B, control conditions (RL ¼ 49 cmH2O s/L). C, bronchoconstriction induced by aerosolized methacholine (MCh) at
16 mg/mL. Note the clear increase in end-inspiration Pes; RL increased by 85% (RL ¼ 91 cmH2O s/L). D, recordings following aclidinium inhalation (total dosage 4 mg/mL; nebulizer
output at 1 mL/min) before MCh challenge (RL ¼ 51 cmH2O s/L). E, challenge with aerosolized MCh at 16 mg/mL 90 min after aclidinium inhalation. Note the virtually absence of
changes in both recorded variables and thus in RL (RL ¼ 56 cmH2O s/L; decrease in RL > 90%), revealing the protective effect on MCh-induced bronchoconstriction.
D. Mutolo et al. / Pulmonary Pharmacology & Therapeutics 38 (2016) 1e9 3for 5min to 1M nebulized citric acidmonohydrate (Sigma-Aldrich).
Chemical stimulation was performed by using aerosolized citric
acid, that exerts its action on airway receptors innervated by Ad-
and C-fibres [3], since the rabbit does not cough in response to
capsaicin [35,36]. Accordingly, TRPV1 receptors are scarcely
expressed in the rabbit respiratory system [29]. In our experience,
rabbits do not cough at all in response to capsaicin, but about 40% of
them respond to citric acid with variable intensity (see also [35]
and the Discussion for further comments on the variability in
cough sensitivity). Citric acid was freshly dissolved in 0.9% NaCl
solution and nebulized via an ultrasonic nebulizer (Projet, Artsana,
Grandate, CO, Italy). The number of coughs during the 5-min citric
acid challenge was evaluated by two trained observers unaware of
the treatment used and the mean of the two observer's counts was
taken as the final count. As already reported [23,24], coughs were
recognized mainly from the characteristic behaviour of the animal
and the sound produced, and readily distinguished from sneezing.
In addition, cough sounds were recorded by amicrophone placed in
the box andmonitored both visually and acoustically, making use of
a personal computer equipped with an analog-to-digital interface
(Digidata 1440, Molecular Devices) and appropriate software
(Axoscope, Molecular Devices). Cough sounds displayed charac-
teristics similar to those observed during cough challenges in
anesthetized animals. All studies were carried out at the same time
of day. The animals were randomly assigned to two groups (10 for
each group) to undergo the following inhalation treatments
(nebulizer output set at 1 mL/min) for 10 min: 1) aclidinium
(aerosolized 400 mg/mL; total dosage 4 mg); 2) tiotropium (aero-
solized 20 mg/mL; total dosage 200 mg). The experimental protocol
was as follows: a) control trials (first citric acid challenge) were
performed on each group by exposing the rabbits for 10 min to an
aerosol of each vehicle solution and after a ~90-min delay to a citricacid aerosol. The number of coughs was counted; b) after an in-
terval of 5e7 days scheduled to avoid tachyphylaxis [23,24], the
animals of each group were treated either with aerosolized acli-
dinium or tiotropium for 10 min and after a ~90-min lag were
exposed to a citric acid aerosol (second citric acid challenge). The
number of coughs was counted again. To reduce as much as
possible the number of animals employed, we compared vehicle-
treated vs. LAMA-treated rabbits. On the other hand, we were
aware of the absence of vehicle-induced effects on cough responses
to citric acid inhalation (Student's paired t-tests) in awake animals
from previous trials using 0.9% NaCl solution (n ¼ 7; P > 0.05) or
low (5%) DMSO concentrations (n¼ 6; P > 0.05) in rabbits devoted
to other studies (unpublished observations). Rabbits that did not
cough in response to citric acid inhalation were not included in the
study.2.4. Experiments on anesthetized animals
Experiments were performed on 20 male New Zealand white
rabbits (3.3e3.8 kg) anesthetized with pentobarbital sodium
(40 mg/kg i.v., supplemented by 2e4 mg/kg every 30 min). The
general characteristics of these preparations were similar to those
already described for MCh experiments. The C3 or C5 phrenic root
on one side was prepared for recordings. Bipolar platinum elec-
trodes were used to record efferent phrenic nerve activity from the
central stump of one cut and desheathed phrenic root. Wire elec-
trodes were used to record abdominal muscle electromyographic
(EMG) activity. Phrenic and abdominal activities were amplified,
full-wave rectified, and “integrated” (low-pass RC filter, time con-
stant 100 ms). Arterial blood pressure and end-tidal CO2 partial
pressure were recorded. Cardiorespiratory variables were acquired
and analyzed using a personal computer, equipped with an analog-
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priate software (Axoscope, Molecular Devices).
Both mechanical and chemical stimulation of the tracheobron-
chial treewere employed to induce cough. All anesthetized animals
coughed in response to both types of stimuli. Mechanical stimu-
lation was delivered by a custom-built device recently described
and validated [27,28] using a 0.5 mm diameter nylon fibre with a
smoothed tip inserted through a lateral port of the tracheal can-
nula. The device allowed to set the number of forth and back
movements or cycles (1e3 cycles), shaft velocity (10e20 mm/s),
and shaft displacement (10e20 mm). Mechanical stimulation was
adjusted to the following parameters: 1 cycle,15mm/s velocity, and
15 mm displacement. These parameters proved to produce a bout
of 2e4 coughs. Chemical stimulation of the tracheobronchial tree
was performed by means of 1 M citric acid inhalation. Citric acid
was delivered by an ultrasonic nebulizer (Projet, Artsana). The
opening of the tracheal cannula, through which the rabbits were
spontaneously breathing, was exposed to a steady stream of the
nebulized citric acid solution for ~3 s. This short period as well as
time intervals between chemical challenges >10 min proved to be
adequate to avoid tachyphylaxis (for details on chemical stimula-
tion see Ref. [25]). Chemical stimulation was always applied
2e3 min after mechanically-induced cough and caused a bout of
several coughs that could be followed by a tachypneic response.
The animals were randomly assigned to one of the two experi-
mental groups (10 for each group) to undergo inhalation treat-
ments (nebulizer output set at 1 mL/min) for 1 minwith aclidinium
(4 mg/mL) or tiotropium (200 mg/mL). Owing to the absence of
vehicle effects on cough responses in awake animals (see above) as
well as on MCh-induced bronchoconstriction, we reasonably
inferred that vehicle solutions were ineffective also in anesthetized
preparations. Thus, we preferred to omit control trials with vehicle
solutions to minimize as much as possible the number of employed
animals (separate experiments) or, alternatively, to avoid a too long
interval between control trials and LAMA effects. This time delay
could possibly lead to a deterioration of the preparation (trials
executed with vehicle solution and LAMA in the same animal).
Cough was induced by both mechanical (3 trials performed in
succession at ~1-min interval) and chemical (1 trial) stimulation in
each animal before (control) and ~90min after drug administration.
The stimulation protocol was repeated at appropriate intervals
(~5 min for mechanical stimulation and 10e15 min for citric acid
inhalation) for about further 120 min to follow the recovery pro-
cess. No attempt was made to investigate the recovery process for
longer time periods owing to the very long-lasting duration of
drug-induced effects [32]. All stimulation procedures were per-
formed at least 5e6 min after each supplemental dose of pento-
barbital to avoid its possible immediate influence on the recorded
variables.
Respiratory variables were measured during eupneic breathing
and reflex responses. The inspiratory (TI) and expiratory (TE) times,
as well as the total duration of the respiratory cycle (TT) were
measured on recordings of raw phrenic nerve activity [28,37]. The
respiratory frequency was subsequently calculated (breaths/min).
Peak amplitude (arbitrary units) of the phrenic nerve activity and
abdominal EMG activity were measured on integrated traces and
normalized by expressing them as a fraction (or percentage) of the
highest achievable amplitude observed in each animal, i.e., in
relative units (RU). Breathing pattern variables were measured for
an average of five consecutive breaths prior to and following drug
administrations. Furthermore, systolic and diastolic blood pres-
sures were measured at 2 s intervals and mean arterial pressure
was calculated as the diastolic pressure plus one-third of the pulse
pressure. The measurement periods of cardiorespiratory variables
were the same selected for cough-related variables (see below).Owing to the small variations in respiratory and cardiovascular
variables within each measurement period, average values were
taken as single measurements for the purpose of analysis.
The cough motor pattern in response to mechanical or chemical
stimulation of the tracheobronchial tree is characterized by
repeated coughs. Respiratory variables of coughs (cough-related
variables) included the cough-related TT, TI and TE, peak phrenic
amplitude (RU), peak abdominal activity (RU) and the cough
number, i.e., the number of coughs following each stimulation.
Cough-related variables were measured and averaged before and
after drug administration at the timewhen the maximum response
occurred (three trials for mechanical stimulation and a single trial
for citric acid inhalation). The average values of cough-related
variables were taken as single measurements for subsequent sta-
tistical analysis. On some occasions, an expiration reflex could
occur as the first motor event in a cough epoch [1,36,38]. Expiration
reflexes were not considered for data analysis. For a discussion on
the expiration reflex, see our previous reports [8,9,11,25,26].2.5. Statistical analysis
In unanesthetized animals, the number of coughs for each citric
acid challenge was counted and the mean value for each group
calculated. Changes in the number of coughs induced by each
treatment were evaluated by Student's paired t-tests. The changes
in the number of coughs due to the different treatments were
compared by unpaired t-tests.
In anesthetized animals, the effects of each individual treatment
on cough-related variables were compared by means of Student's
paired t-tests. Changes in the cough number, i.e. the only cough-
related variable that resulted to be significantly different from
control, were compared by means of unpaired t-tests (i.e. aclidi-
nium vs. tiotropium). Similarly, changes in the cough number in
response to citric acid inhalation induced by aclidinium or tio-
tropium in awake and anesthetized animals were compared by
unpaired t-tests. In the anesthetized preparations, the same sta-
tistical analysis was used to compare mean changes in the cough
number in response to mechanical and chemical stimuli for each
employed LAMA. Changes in the cough number were also
expressed as percentage variations of control values. All reported
values are means ± standard error of the mean (SEM). P < 0.05 was
considered as significant.3. Results
3.1. Unanesthetized animals
Significant reductions in the cough number were observed
following 10-min inhalation of aclidinium (from 31.90 ± 7.15 to
6.90 ± 3.69, 77.3 ± 9.4%, n ¼ 10; P < 0.01) or tiotropium (from
35.70 ± 6.20 to 19.01 ± 5.56,38 ± 19%, n¼ 10; P < 0.05) compared
with the corresponding control treatment with vehicle solutions.
No significant difference between the effects of the two drugs were
seen, although aclidinium showed a tendency to cause more
marked antitussive effects. It should be recalled that the employed
dose of each drug is that proved to fully express its protective action
on cholinergic-induced bronchoconstriction. A useful graphic rep-
resentation of the results is provided in Fig. 2, where individual
control values of the cough number and the respective decreases
~90 min following 10-min inhalation of each drug are reported. A
complete suppression of the cough reflex was observed in some
preparations with both treatments (aclidinium: n ¼ 6; tiotropium:
n ¼ 2).
Fig. 2. Effects on the cough number induced by aclidinium or tiotropium in unanes-
thetized rabbits. Changes in the cough number induced by citric acid in each individual
rabbit ~90 min following vehicle inhalation (control) as well as ~90 min after inha-
lation of aclidinium (A) or tiotropium (B). LAMAs were administered 5e7 days after the
vehicle treatment. Note the complete suppression of the cough reflex in some
preparations.
Fig. 3. Cough number induced by mechanical or chemical stimulation of the
tracheobronchial tree before (control conditions) and ~90 min following inhalation of
aerosolized aclidinium or tiotropium in anesthetized rabbits. Values of the cough
number evoked in each rabbit by mechanical stimulation before and after inhalation of
aclidinium (A) or tiotropium (B) are reported. Individual values of the cough number in
response to chemical stimulation before and after drug inhalation are reported in C
and D. Note the complete absence of the cough response to mechanical stimulation
observed in some preparations following both treatments.
D. Mutolo et al. / Pulmonary Pharmacology & Therapeutics 38 (2016) 1e9 53.2. Anesthetized animals
Cough responses induced by mechanical stimulation were
completely suppressed in some preparations with both treatments
(aclidinium: n¼ 5; tiotropium: n¼ 4). Cough responses induced by
chemical stimulation of the tracheobronchial tree were reduced,
but not abolished by both treatments. In animals with depressed
cough responses, the cough number significantly changed, at
variance with the other cough-related variables that did not show
any significant variation. The overall data showed that the cough
number in response to mechanical stimulation varied from
3.39 ± 0.16 to 0.94 ± 0.35 (74.3 ± 9.2%, n¼ 10; P < 0.001) and from
3.17 ± 0.18 to 0.99 ± 0.33 (70.9 ± 9.4%, n ¼ 10; P < 0.001) for
aclidinium and tiotropium, respectively. Further, the cough number
in response to citric acid inhalation changed for aclidinium from
4.20 ± 0.47 to 3.14 ± 0.37 (25.1 ± 5.1%, n ¼ 10; P < 0.005) and for
tiotropium from 4.23 ± 0.36 to 3.13 ± 0.24 (23.8 ± 4.5%, n ¼ 10;
P < 0.005). No significant differences were observed between the
effects of aclidinium and tiotropium. These data are illustrated by
graphic representations of individual values of the cough number
for each animal before and after treatment (Fig. 3). LAMA antitus-
sive effects on cough responses induced by mechanical stimulation
were more intense than those evoked by citric acid inhalation
(P < 0.05). Data concerning cough-related variables that did not
change have not been shown. Nevertheless, control values of these
variables under control conditions have already been extensively
reported [8e11,23e25]. Note that the reductions in the cough
number in response to chemical stimulation induced by aclidinium
or tiotropium in the anesthetized preparations were significantly
lower than those observed in awake animals (P < 0.001 and
P < 0.05, respectively). The effects of aclidinium on the cough reflex
induced by mechanical and chemical stimulation of the tracheo-
bronchial tree are shown through examples of original recordings
in Figs. 4 and 5, respectively. Since the effects of the two drugs on
cough responses induced by mechanical and chemical stimulation
were similar, only the effects induced by aclidinium have been
reported. No recovery of control cough responses was present for
both treatments within the observation period. Both aclidinium
and tiotropium did not cause any change either in arterial blood
pressure or in baseline respiratory activity. For a general appraisal
of cardiorespiratory variables under control conditions see our
previous studies [9,10,23e26].4. Discussion
This is the first preclinical study comparing the effects of acli-
dinium and tiotropium on the cough reflex induced by mechanical
and chemical stimulation of the tracheobronchial tree in healthy
animals. These two LAMAs displayed antitussive effects in un-
anesthetized rabbits in response to citric acid inhalation. In anes-
thetized animals, aclidinium and tiotropium caused similar
antitussive effects that were less intense for cough responses
induced by chemical stimulation. Interestingly, the results strongly
suggest that inhaled LAMAs have a possible novel antitussive
mechanism of action, probably unrelated to their anticholinergic
activity and to their action on TRPV1 receptors, and involving acid-
sensing ion channels (ASICs) and mechanoreceptors of cough-
related airway sensory afferents.
4.1. Methodological considerations and general remarks
Despite some rabbits could not present a prompt cough reflex
[1], this animal species is a very suitable model for studies on the
physiology and pharmacology of cough [7e11,23e26,35,39e43].
Admittedly, suggestions for new antitussive agents could stem
more directly from studies on animal models of human lung dis-
eases characterized by cough hypersensitivity, although the results
Fig. 4. Examples of cough responses induced in anesthetized rabbits by mechanical stimulation under control conditions and ~90 min after aclidinium inhalation. After anti-
cholinergic treatment, cough responses could be either only depressed or completely abolished. Traces are: Phr IN, phrenic integrated neurogram; Phr N, phrenic neurogram; Abd
IEMG, abdominal integrated electromyographic activity; Abd EMG, abdominal electromyographic activity. The onset of mechanical stimulation is indicated by arrows.
Fig. 5. Examples of cough responses induced in one anesthetized rabbit by citric acid inhalation under control conditions and ~90 min after aclidinium inhalation. After anti-
cholinergic treatment, cough responses were depressed, but in no case completely abolished. Traces are: Phr IN, phrenic integrated neurogram; Phr N, phrenic neurogram; Abd
IEMG, abdominal integrated electromyographic activity; Abd EMG, abdominal electromyographic activity. Stimulation periods are indicated by filled bars.
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new antitussive agents [6,7]. Nevertheless, we are confident that
investigations performed on healthy preparations can provide
useful insights into the regulation of the cough reflex as well as
hints for further studies on this reflex and possibly for the devel-
opment of novel antitussive strategies. Preclinical studies have
indicated that aclidinium may have a faster onset of action than
tiotropium, but comparable protective effects on bronchocon-
striction [32,33]. In addition, since it has been reported that the
clinical dose of tiotropium 18 mg is very low with respect to the
clinical dose of aclidinium 400 mg [14], we made an attempt to find
the isoeffective dose of the two drugs as far as bronchodilation is
concerned. The potency of these two LAMAs has been previously
assessed in guinea pigs [32,33]. Aclidinium 100 mg/mL and tio-
tropium 10 mg/mL produced 1 h post-administration equi-effective
(97e98%) inhibition of acetylcholine-induced bronchoconstriction
that lasted several hours. In the present study, the isoeffective
single aerosolized doses resulted to be 4 mg/mL and 200 mg/mL for
aclidinium and tiotropium, respectively. The discrepancy with
these previous findings may be related to the differences in the
animal species and the bronchoconstrictor agent employed.
The time interval of 90 min between drug administration and
cough challenge was higher than that of 1 h used by Birrell et al.
[17]. It was scheduled to ensure the complete development of
bronchodilator effects (see Methods). It is noteworthy that changes
in the ongoing respiratory activity or in arterial blood pressure, that
have been proved to affect the timing and intensity of cough re-
sponses [8,24,37], were not induced by the two employed LAMAs.
4.2. Effects of treatments
Present results on aclidinium are consistent with previous
findings obtained in cigarette smoke-exposed guinea pigs [22] as
well as in COPD patients [12,13] inwhom aclidinium proved to have
antitussive effects more intense than tiotropium. Apart from the
study by Birrell et al. [17] on guinea pigs, there are a few other
investigations on the antitussive effects of tiotropium both in ani-
mal species [44] and patients [12,13,16,18,19]. Recently, at variance
with previous and present results, a lack of tiotropium antitussive
effects on ozone-induced hypertussive responses in rabbits has
been reported [7]. The reasons of the discrepancy with our results
are not clear, but could be tentatively attributed to differences in
the experimental conditions. In more detail, our animals were
selected on the basis of their responsiveness to citric acid inhalation
and most of them presented control cough responses more intense
than those of the rabbits employed by Clay et al. [7]. Furthermore,
we cannot exclude that ozone-induced sensitization, i.e. a treat-
ment that probably involves a complex series of phenomenawithin
the airways, could have affected the responsiveness of pulmonary
cough-related receptors to the employed drugs. In this context, it
should be mentioned that differences in cough sensitivity and
regulation do exist not only between different animal species [45],
but also within the same species and, according to our experience,
in New Zealand white rabbits too (see also [35] and [40]). Finally,
our results are corroborated by the observations on anesthetized
animals obtained under controlled and less variable conditions.
According to previous results [17,18], bronchodilation does not
seem to be the mechanism by which LAMAs downregulate cough
responses. This conclusion is also supported by the results of
several studies showing the inability of bronchodilation or bron-
choconstriction to alter cough receptor sensitivity and produce
cough ([46e50], see also [18] for further Refs.). The main difference
reported in the literature between unanesthetized and anes-
thetized animals is that the C-fibre stimulation has consistently
failed to evoke coughing in the latter [2,4,48,49,51e55]. It is wellknown that citric acid activates both Ad- and C-fibres in most an-
imal species including the rabbit, likely owing to the contribution of
both ASICs and, to some extent, C-fibre TRPV1 receptors
([2,48,56e58] also for further Refs.). Thus, while in the absence of
anesthesia both types of afferents are engaged along with the
related reflex pathways, only Ad-fibres and their pathways are
probably involved in cough responses obtained in anesthetized
animals. The effects we observed in awake rabbits strongly suggest
that the mechanism of action of the employed LAMAs on cough
receptors cannot be the same suggested by Birrell et al. [17], since
TRPV1 receptors are very scarcely expressed in the rabbit respira-
tory system [59]. Accordingly, the rabbit, as already stated in the
Methods, does not cough in response to inhaled capsaicin and, in
addition, does not develop the pulmonary chemoreflex in response
to capsaicin injected into the pulmonary circulation [35,36,60,61].
Thus, other receptors in addition to TRPV1 should be taken into
consideration in themediation of LAMA antitussive effects. It seems
obvious to suggest that ASICs on Ad- and C-fibre endings are
involved in cough production by 1 M citric acid in awake rabbits
and that LAMAs probably act especially on C-fibre ASICs without an
important involvement of TRPV1 receptors. Consistently with this
interpretation, significantly less pronounced effects of LAMAs on
citric acid-induced cough were observed in anesthetized animals
where C-fibres are not active in cough production. In addition,
these LAMA effects were lower than those observed in cough re-
sponses induced by mechanical stimulation. In this context, it
should be recalled that receptors involved in cough production are
polymodal and may express either a single type of channel sensi-
tive to both acid and punctate stimuli or two different channel
types, i.e. one for each modality. Evidence has been provided that
ASICs are involved in mechanosensory function (e.g. Refs. [62,63]),
but also that separate mechano-sensitive channels may exist in the
tracheobronchial tree (e.g. Refs. [64e66]) or elsewhere (e.g.
Refs. [67,68]). Present results may suggest two separate types of
channels. Furthermore, the possibility should be also considered
that the two channel types are located on different sensory Ad-fi-
bres. However, the exact mechanism involved in the activation of
mechano-sensitive channels of tracheobronchial tree receptors is,
at present, unknown. Nevertheless, our results in anesthetized
animals could imply that these drugs also affect, to some extent,
ASICs on Ad-fibres. Interestingly, the results in anesthetized ani-
mals strongly suggest that LAMAs have an important role in cough
downregulation through an action on Ad-mechanoreceptors of the
tracheobronchial tree and that they could act on airway mecha-
noreceptors also in awake animals, even if a direct evidence for this
is not available. In this context, it is worth recalling that both C-fibre
endings and Ad-receptors are responsive to mechanical stimuli [3].
A subtype of airway receptors has been described in the anes-
thetized guinea pigs and called “cough receptors” [48e50]. These
receptors, innervated by slowly conducting Ad-fibres, have been
suggested to play an essential role in regulating the cough reflex.
They are sensitive to punctate mechanical stimuli and acid, but
unresponsive to changes in luminal pressure, to capsaicin, brady-
kinin or hypertonic saline and do not express TRPV1 channels. Our
results are consistent with the possible role of this type of receptors
in cough production both in awake and anesthetized rabbits,
although, to our knowledge, there is no evidence of their presence
in the tracheobronchial tree of this animal species.
As proposed in our previous reports ([8,11,28] also for further
Refs), cough and nociception share similar central and peripheral
features. This led to the proposal that agents involved in the control
of pain sensation could be also effective in the cough regulation and
viceversa (see e.g. Refs. [6,69]). In particular, it is well known that
ASICs are involved not only in cough production, but also in pain
sensation [70e72]. Here we provide for the first time evidence that
D. Mutolo et al. / Pulmonary Pharmacology & Therapeutics 38 (2016) 1e98LAMAs display antitussive effects through an action on ASICs and
mechanoreceptors in the rabbit tracheobronchial tree. It should
also be acknowledged that aclidinium is hydrolyzed into inactive
metabolites more rapidly than tiotropium or other LAMAs [32,73],
thus minimizing its potential for systemic side effects. The route of
administration, i.e. via inhalation, that avoids central effects char-
acteristic of many systemically administered antitussive drugs,
contributes to its favorable safety profile. Further studies on the
role of ASIC blockers or modulators could provide insights into the
neural mechanisms underlying the cough reflex and possibly lead
to novel therapeutic strategies for both cough and pain.
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